Мальта - англійська - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - powder and solvent for solution for infusion or injection - lenograstim 13.4 million iu - immunostimulants

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

chugai sanofi-aventis - lenograstim - withdrawn form

Індія - англійська - Central Drugs Standard Control Organization

sanofi aventis - lenograstim,human albumin,mannitol,polysorbate,sod.dihydrogen phos. - vial - 33.6miu.,1mg,50mg,0.1mg,6.5(ph) - vial

Намібія - англійська - Namibia Medicines Regulatory Council

aventis pharma (pty) limited - combination - injection - lenograstim 33,6 miu (263 micrograms) - a recombinant glycoprotein equiv. to the human granulocyte colony stimulating factor (rh

Європейський Союз - англійська - EMA (European Medicines Agency)

teva b.v. - lipegfilgrastim - neutropenia - immunostimulants, , colony stimulating factors - lonquex is indicated in adults and in children 2 years of age and older for reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).

Ізраїль - англійська - Ministry of Health

abic marketing ltd, israel - lipegfilgrastim - solution for injection - lipegfilgrastim 6 mg / 0.6 ml - lipegfilgrastim - reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).

Сінгапур - англійська - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - lipegfilgrastim - injection, solution - lipegfilgrastim 6.00 mg/0.6ml

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - lipegfilgrastim - solution for injection - 10mg/1ml

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - lipegfilgrastim, quantity: 6 mg - injection, solution - excipient ingredients: acetic acid; polysorbate 20; sorbitol; sodium hydroxide; water for injections - lonquex? is indicated for reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes)